FDA Requiring Labeling Changes to Benzodiazepine Prescribing Information
Update to Boxed Warning must include risks for abuse, misuse, addiction, physical dependence, withdrawal reaction
Guidelines Updated for Managing Dyslipidemia to Cut CVD Risk
Moderate-dose statin therapy recommended for patients with 10-year CVD risk ≥12 percent
Cognition-Enhancing Supplements May Contain Unapproved Drugs
Five unapproved pharmaceutical drugs ID'd in supplements marketed to improve memory, cognition
Teens’ Mental Illness Treatment May Not Follow Guidelines
Variance in treatment occurs within and across ZIP codes, suggesting non-supply-side variables
Heavy Sugar-Sweetened Drink Intake Decreasing Overall in U.S.
Heavy SSB intake up for adults ≥60 years; no change seen for those age 40 to 59 years, non-Mexican Hispanics
Acute Kidney Injury Ups Risk for Death in COVID-19 Patients
Findings based on large study of hospitalized patients in New York City early in the pandemic
Measures of Central Adiposity Linked to All-Cause Mortality
Waist circumference, waist-to-hip ratio, waist-to-height ratio linked to increased all-cause mortality
Major Adverse CV Event Risk Reduced With SGLT2 Inhibitors
Risks for MACE, MI, cardiovascular death, heart failure, all-cause mortality lower versus DPP-4 inhibitors
Children’s Routine Care Plummets During Pandemic
Immunizations increased since May, but huge jump needed to make up for missed vaccinations since the spring
Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
If it passes final round of human tests, SinoVac will apply to the FDA to sell CoronaVac vaccine
